Malignancies in pediatric AIDS

Current Opinion in Pediatrics

Volumn 8, Issue 1, 1996, Pages 45-49

  Mueller, Brigitta U ^a   Pizzo, Philip A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CARCINOGENESIS; CHILDHOOD CANCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SOFT TISSUE TUMOR; UTERINE CERVIX CARCINOMA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; CHILD; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASMS; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 0029917640     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199602000-00010     Document Type: Review

References (42)

1. Mueller BU, Pizzo PA: Cancer in children with primary or secondary immunodeficiencies. J Pediatr 1995, 126:1-10. A comprehensive review of the epidemiology and the clinical manifestations of neoplasms in immunocompromised children.
2. Mueller BU: Role of cytokines in children with HIV infection. Int J Pediatr Hematol Oncol 1995, 2:151-161.
3. Centers for Disease Control and Prevention: US HIV and AIDS cases reported through December 1994. HIV/AIDS Surveill Rep 1995, 6:1-39.
4. Tao Q, Srivastava G, Loke SL, Liang RHS, Liu YT, Ho FCS: Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma. Int J Cancer 1994, 58:33-39.
5. McClain KL, Leach CT, Jenson HB, Joshi W, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG, Murphy SB: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995, 332:12-18. This paper demonstrates for the first time the presence of the EBV genome in smooth muscle tumors from patients with AIDS, suggesting that EBV has a role in the pathogenesis of these lesions.
6. Lee ES, Locker J, Nalesnik M, Teyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS: The association of Epstein-Barr virus with smooth muscle tumors occurring after organ transplantation. N Engl J Med 1995, 332:19-25. The EBV genome is also present in smooth muscle tumors from patients who have undergone an organ transplantation, further supporting a pathogenic link between EBV infection and certain malignancies in the setting of a compromised immune system.
7. Mathur A, Kamat DM, Filipovich AH, Steinbuch M, Shapiro RS: Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferatlve disorders. Transplantation 1994, 57:1042-1045.
8. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995, 373:438-441.
9. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456.
10. Filipovich AH, Mathur A, Kamat D, Kersey JH, Shapiro RS: Lymphoprollferatlve disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994, 5:91-112. A comprehensive review of LPDs observed in patients with immunodeficiencies, with a discussion of epidemiology, pathogenasis, and treatment. Data based on Immunodeficiency Cancer Registry of the University of Minnesota.
11. Mishalani SH, Lones MA, Said JW: Multilocular thymic cyst: a novel thymic lesion associated with human immunodeficiency virus infection. Arch Pathol Lab Med 1995, 119:467-470.
12. Cabanillas F, Armitage J, Pugh WC, Weisenburger D, Duvic M: Lymphomatous papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Intern Med 1995, 122:210-217.
13. Tirelli LJ, Vaccher E, Zagonel V, Talamini R, Bernardi R, Tavio M, Gloghini A, Merola MC, Monfardini S, Carbone A: CD30 (Kl-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinico-pathological study from a single institution that also includes 80 patients with other human Immunodeficiency virus-related systemic lymphomas. J Clin Oncol 1995, 13:373-380. CD30+ tumors are quite common in HIV-infected patients. The authors found a difference in the incidence of the T cell subtype (none in HIV-positive patients vs 22% in HIV-negative patients) as well as a tendency to more advanced disease at diagnosis and more rapid course of disease in HIV-infected patients.
14. Teruya-Feldstein J, Temeck BK, Sloas MM, Kingma DW, Raffeld M, Pass HI, Mueller B, Jaffe ES: Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 1995, 19:357-363.
15. Shibata D: Biologic aspects of AIDS-related lymphoma. Curr Opin Oncol 1994, 6:503-507.
16. Herndier BG, Kaplan LD, McGrath MS: Pathogenesis of AIDS lymphomas. AIDS 1994, 8:1025-1049.
17. Bhatia K, Spangler G, Gaidano G, Hamdy N, Dalla-Favera R, Magrath I: Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 1994, 84:883-888. The authors analyzed 30 cases of high- and intermediate-grade AIDS-associated NHL for mutations in the c-myc coding region. Nineteen of the NHLs analyzed contained a c-myc rearrangement, and in 10 of these the c-myc gene was mutated in its coding region.
18. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R: Rearrangements of the bcl-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 1994, 84:397-402.
19. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191. The authors found DNA fragments of the newly described KS-associated herpesvirus in eight body cavity-based lymphomas from HIV-infected patients. All eight lymphomas also contained the EBV genome. This suggests a pathogenic role of this novel herpesvirus in AIDS-related body cavity-based lymphomas.
20. Bergmann OJ, Madsen M, Kristensen JS, Black FT: Treatment of AIDS-associated lymphoma with interferon-α and intravenous gammaglobulin. AIDS 1995, 9:305-306.
21. Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay J-Y, Gabarre J, Gaillard J-P, Brochier J, Raphael M, et al.: Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 1994, 84:2472-2479.
22. Rubio R, Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid: Hodgkin's disease associated with human immunodeficiency virus infection: a clinical study of 46 cases. Cancer 1994, 73:2400-2407.
23. Errante D, Zagonel V, Vaccher E, Serraino D, Bernardi D, Sorio R, Trovo M, Carbone A, Monfardini S, Tirelli U: Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survival. Ann Oncol 1994, 5(suppl 2):S37-S40.
24. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, Franceschi S, Boiocchi M, Carbone A: Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologie features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995, 13:1758-1767.
25. Miles SA: Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol 1994, 6:497-502. A comprehensive review of the current understanding of KS in HIV disease.
26. Scinicariello F, Dolan MJ, Nedelcu I, Tyring SK, Milliard JK: Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma. Virology 1994, 203:153-157.
27. McGrath MS, Shiramizu BT, Herndier BG: Identification of a clonal form of HIV in early Kaposi's sarcoma: evidence for a novel model of oncogenesis, sequential neoplasia. J Acquit Immune Delic Syndr Hum Retrovirol 1995, 8:379-385.
28. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P: A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995, 1:707-708.
29. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995, 332:1181-1185. The authors analyzed DNA in tissue samples from patients with AIDS-associated KS, patients with classic KS, and HIV-seronegative homosexual men with KS. The same herpesvirus-like DNA sequences were present in 95% of all samples and were more than 98% identical for the three types of KS, suggesting that all three are caused by the same agent.
30. Rady PL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, Tyring SK: Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995, 345:1339-1340.
31. Webster GF: Local therapy for mucocutaneous Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Dermatol Surg 1995, 21:205-208.
32. Lilenbaum RC, Ratner L: Systemic treatment of Kaposi's sarcoma: current status and future directions. AIDS 1994, 8:141-151.
33. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM: Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudlne in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1994, 6:1695-1699.
34. Paredes J, Kahn JO, Tong WP, Feldstein ML, Lin S, Bennett JM, Metroka CE, Ratner L, Krown SE: Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group. J Acquit Immune Defic Syndr Hum Retrovirol 1995, 9:138-144.
35. Saville MW, Lietzau J, Pluda JM, Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S, Yarchoan R: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 1995, 346:26-28.
36. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM: All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia 1994, 8(suppl 3):S26-S32.
37. Bonhomme L, Fredj G, Ecstein E, Maurisson G, Farabos C, Misset JL, Jasmin C: Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin. Am J Hosp Pharm 1994, 51:2417-2419.
38. Johnstone FD, McGoogan E, Smart GE, Brettle RP, Prescott RJ: A population-based, controlled study of the relation between HIV infection and cervical neoplasia. Br J Obstet Gynaecol 1994, 101:986-991.
39. Stratton P, Ciacco KH: Cervical neoplasia in the patient with HIV infection. Curr Opin Obstet Gynecol 1994, 6:86-91.
40. Palefsky JM: Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994, 8:283-295.
41. Wright TC, Ellerbrock TV, Chiasson MA, van Devanter N, Sun X-W, The New York Cervical Disease Study: Cervical Intraepithelial neoplasia in women infected with human Immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994, 84:591-597. HIV-seropositive (n = 398) and HIV-seronegative (n = 357) women were enrolled in this study. Twenty percent of the HIV-seropositive women as compared with 4% of the seronegative women had a colposcopically confirmed cervical intraepithelial neoplasia (odds ratio, 5.7; P< 0.001), but no invasive cancers were found. The sensitivity and specificity of Papanicolaou tests in seropositive women were 81% and 87%, respectively, suggesting that Papanicolaou tests should be effective for detecting cervical disease in this population.
42. Centers for Disease Control and Prevention: Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morbid Mortal Wkly Rep 1994, 43:1-12.